Humana CFO reports stock acquisition and tax-related share disposal

Humana Inc. reported insider share transactions by its Chief Financial Officer, Celeste Mellet, dated 12/15/2025.

Rhea-AI Filing Summary

Humana Inc. reported insider share transactions by its Chief Financial Officer, Celeste Mellet, dated 12/15/2025. She acquired 2,128 shares of Humana common stock at a price of $0, and 1,222 shares were disposed of at $270.155 per share to pay tax liabilities on vesting shares, with no value received in return.

Following these transactions, Mellet beneficially owned 28,454 Humana shares directly. This total includes 27,548 restricted stock units, each representing a contingent right to receive one share of Humana common stock under the Company's 2019 Amended & Restated Plan.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Mellet Celeste

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Humana Common	2,128	$0.00	$0.00
Exercise Price or Tax Liability	Humana Common	1,222	$270.155	$330K

Holdings After Transaction: Humana Common — 28,454 shares (Direct)

Footnotes (2)

1. F1. Includes 27,548 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.
2. F2. Shares disposed of represent payment of tax liability for shares vesting 12/15/25 in which no value was received in return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who reported an insider stock transaction for HUM and what is their role?

The reporting person is Celeste Mellet, who serves as Chief Financial Officer of Humana Inc.

When did the reported Humana (HUM) insider transactions occur?

The reported transactions in Humana common stock occurred on 12/15/2025.

How many Humana shares did the CFO acquire and at what price?

Celeste Mellet acquired 2,128 shares of Humana common stock at a price of $0 per share.

How many Humana shares were disposed of by the CFO and for what reason?

1,222 shares of Humana common stock were disposed of at $270.155 per share. The shares disposed of represent payment of tax liability for shares vesting on 12/15/2025, and no value was received in return.

How many Humana (HUM) shares does the CFO beneficially own after the transactions?

After the reported transactions, Celeste Mellet beneficially owned 28,454 Humana shares directly.

What restricted stock units are included in the CFO’s Humana holdings?

The reported holdings include 27,548 restricted stock units, each representing a contingent right to receive one share of Humana Inc. common stock under the Company's 2019 Amended & Restated Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/17/2025 - 03:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mellet Celeste

(Last) (First) (Middle)

HUMANA INC.

500 W. MAIN ST.

(Street)

LOUISVILLE KY 40202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Humana Common	12/15/2025		M		2,128	A	$0	29,676	D
Humana Common	12/15/2025		F		1,222(2)	D	$270.155	28,454(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 27,548 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

2. Shares disposed of represent payment of tax liability for shares vesting 12/15/25 in which no value was received in return.

	Celeste Mellet	12/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.